{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:02:15Z","timestamp":1792512135595,"version":"4.5.0"},"reference-count":64,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Rheumatology"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1080\/030097401316909486","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:21:11Z","timestamp":1027682471000},"page":"185-188","source":"Crossref","is-referenced-by-count":63,"title":["Rheumatic diseases and malignancy ? is there an association?"],"prefix":"10.1080","volume":"30","author":[{"family":"Maria Jos\u00e9 Leandro, David A. Isenberg","sequence":"first","affiliation":[{"name":"Centre for Rheumatology, Bloomsbury Rheumatology Unit, University College London Hospitals, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,12]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202063260602"},{"key":"e_1_2_1_3_1","first-page":"9","volume":"6","author":"Chow SF","year":"1995","unstructured":"Chow SF, Gridley G, Mellemkjar Let al. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 1995;6:9\u201313.","journal-title":"Mellemkjar Let al. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control"},{"key":"e_1_2_1_4_1","first-page":"1855","article-title":"Felson D","volume":"21","author":"Zantos D","year":"1994","unstructured":"Zantos D, Zhang Y, Felson D. The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994;21:1855\u20139.","journal-title":"The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199411000-00007"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.12.857"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","unstructured":"Peng JC Sheen TS Hsu MM. Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases. Arch Otolaryngol Head Neck Surg 1995;121: 1298\u2013301.","DOI":"10.1001\/archotol.1995.01890110072013"},{"key":"e_1_2_1_8_1","first-page":"1300","volume":"22","author":"Airio A","year":"1995","unstructured":"Airio A, Pukkala E, Isomaki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 1995;22:1300\u20133.","journal-title":"Isomaki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol"},{"key":"e_1_2_1_9_1","first-page":"1136","article-title":"al","volume":"12","author":"Peters-Golden M","year":"1985","unstructured":"Peters-Golden M, Wise RA, Hochberg M, et al. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985;12:1136\u20139.","journal-title":"Incidence of lung cancer in systemic sclerosis. J Rheumatol"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.7.531"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197903000-00006"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1979.04010080014013"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780281204"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.Suppl_4.846"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360405"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/28.1.65"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1961.01580150005001"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","unstructured":"Jacobsen S Halberg P Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (sclerod-erma). Br J Rheumatol 1998;37: 750\u20135.","DOI":"10.1093\/rheumatology\/37.7.750"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950901)76:5<910::AID-CNCR2820760528>3.0.CO;2-T"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90376-7"},{"key":"e_1_2_1_21_1","first-page":"485","volume":"89","author":"Segel MC","year":"1985","unstructured":"Segel MC, Campbell WL, Medsger TA. Systemic sclerosis and esophageal adenocarcinoma: is increase patient screening necessary? Gastroenterology 1985;89:485\u201391.","journal-title":"Medsger TA. Systemic sclerosis and esophageal adenocarcinoma: is increase patient screening necessary? Gastroenterology"},{"key":"e_1_2_1_22_1","first-page":"1041","article-title":"Systemic sclerosis and malignancy - are they related?","volume":"12","author":"Medsger TA","year":"1995","unstructured":"Medsger TA Jr. Systemic sclerosis and malignancy - are they related? J Rheumatol 1995;12:1041\u20133.","journal-title":"J Rheumatol"},{"key":"e_1_2_1_23_1","first-page":"682","article-title":"Akesson A","volume":"57","author":"Hesselstrand R","year":"1998","unstructured":"Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682\u20136.","journal-title":"Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","unstructured":"Isomaki HA Hakulinen T Jout Senlahti U. Excess risk of lymphoma leukaemia and myeloma in patients with rheumat-oid arthritis. Ann Rheum Dis 1982;41 Supp1:34\u20138.","DOI":"10.1136\/ard.41.Suppl_1.34"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90246-3"},{"key":"e_1_2_1_26_1","first-page":"104","article-title":"Conn DL","volume":"54","author":"Banks PM","year":"1979","unstructured":"Banks PM, Witrak GA, Conn DL. Lymphoid neoplasia follow-ing connective tissue disease. Mayo Clin Proc 1979;54:104\u20138.","journal-title":"Lymphoid neoplasia follow-ing connective tissue disease. Mayo Clin Proc"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(93)90049-7"},{"key":"e_1_2_1_28_1","first-page":"76","article-title":"HA","volume":"24","author":"Myllykangas-Luosujarvi RA","year":"1995","unstructured":"Myllykangas-Luosujarvi RA, Aho K, Isomaki HA. Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol 1995;24:76\u20138.","journal-title":"Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","unstructured":"Symmons DPM Aherm M Bacon PA. Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases. Ann Rheum Dis 1984;43: 132\u201335.","DOI":"10.1136\/ard.43.2.132"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-89-6-888"},{"key":"e_1_2_1_31_1","first-page":"201","article-title":"Isomaki H","volume":"8","author":"Kauppi M","year":"1997","unstructured":"Kauppi M, Pukkala E, Isomaki H. Elevated incidences of hematological malignancies in patients with SjOgren's syn-drome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997;8:201\u20134.","journal-title":"Elevated incidences of hematological malignancies in patients with SjOgren's syn-drome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.5.290"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009749509099305"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400906"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.8.738"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.47.12.988"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.42.4.368"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380815"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80160-0"},{"key":"e_1_2_1_41_1","doi-asserted-by":"crossref","unstructured":"Bologna C Picot M-C Jorgensen C et al. Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate. Ann Rheum Dis 1997;56: 97\u2013102.","DOI":"10.1136\/ard.56.2.97"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305063281806"},{"key":"e_1_2_1_43_1","first-page":"1174","article-title":"Cochand-Priollet B, et al","volume":"22","author":"Liote F","year":"1995","unstructured":"Liote F, Pertuiset E, Cochand-Priollet B, et al. Methotrexate related B lymphproliferative disease in a patient with rheumat-oid arthritis. Role of Epstein-Barr virus infection. J Rheumatol 1995;22:1174\u20138.","journal-title":"Methotrexate related B lymphproliferative disease in a patient with rheumat-oid arthritis. Role of Epstein-Barr virus infection. J Rheumatol"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390223"},{"key":"e_1_2_1_45_1","first-page":"267","article-title":"Mariette X","volume":"65","author":"Sibilia J","year":"1998","unstructured":"Sibilia J, Liote F, Mariette X. Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate. Rev Rhum 1998;65:267\u201373.","journal-title":"Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate. Rev Rhum"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.4.437"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780170407"},{"key":"e_1_2_1_48_1","first-page":"1050","article-title":"Urowitz MB","volume":"39","author":"Abu Shakra M","year":"1996","unstructured":"Abu Shakra M, Cladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus. Arthritis Rheum 1996;39:1050\u20134.","journal-title":"Malignancy in systemic lupus erythematosus. Arthritis Rheum"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400424"},{"key":"e_1_2_1_50_1","first-page":"217","article-title":"al","volume":"46","author":"Ramsey-Goldman R","year":"1998","unstructured":"Ramsey-Goldman R, Mattai SA, Schilling E, et al. Increased risk of malignancy in patients with systemic lupus eryth-ematosus. J Investig Med 1998;46:217\u201322.","journal-title":"Increased risk of malignancy in patients with systemic lupus eryth-ematosus. J Investig Med"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/096120339300200608"},{"key":"e_1_2_1_52_1","doi-asserted-by":"crossref","unstructured":"Sultan SM Ioannou Y Isenberg DA. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatology 2000;39: 1147\u201352.","DOI":"10.1093\/rheumatology\/39.10.1147"},{"key":"e_1_2_1_53_1","first-page":"1478","article-title":"Risk of malignancy in women with systemic lupus erythematosus","volume":"22","author":"Sweeney DM","year":"1995","unstructured":"Sweeney DM, Manzi S, Janosky J, et al. Risk of malignancy in women with systemic lupus erythematosus. J Rheumatol 1995;22:1478\u201382.","journal-title":"J Rheumatol"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.5.1245"},{"key":"e_1_2_1_55_1","first-page":"337","article-title":"Non-Hodgkin's lymphoma associated with primary Sj\u00f6gren's syndrome","volume":"1","author":"Pariente D","year":"1992","unstructured":"Pariente D, Anaya JM, Combe B, et al. Non-Hodgkin's lymphoma associated with primary Sj\u00f6gren's syndrome. Eur J Med 1992;1:337\u201342.","journal-title":"Eur J Med"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390219"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390508"},{"key":"e_1_2_1_58_1","doi-asserted-by":"crossref","unstructured":"Zufferey P Meyer OC Grossin M et al. Primary Sj\u00f6gren's syndrome and malignant lymphoma. A retrospective co-hort study of 55 patients with SS. Scand J Rheumatol 1995;24: 342\u20135.","DOI":"10.3109\/03009749509095178"},{"key":"e_1_2_1_59_1","doi-asserted-by":"crossref","unstructured":"Voulgarelis M Dafni UG Isenberg DA et al. Malignant lymphoma in primary Sj\u00f6gren's syndrome. A multicenter retrospective clinical study by the European Concerted Action on Sj8gren's syndrome. Arthritis Rheum 1999;42: 1765\u201372.","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(98)80040-1"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-89-6-888"},{"key":"e_1_2_1_62_1","first-page":"245","volume":"38","author":"Davidson BKS","year":"1999","unstructured":"Davidson BKS, Kelly CA, Griffiths ID. Primary Sj\u00f6gren's syndrome in the North East of England: a long-term follow-up study. Rheumatology 1999;38:245\u201353.","journal-title":"Griffiths ID. Primary Sj\u00f6gren's syndrome in the North East of England: a long-term follow-up study. Rheumatology"},{"key":"e_1_2_1_63_1","doi-asserted-by":"crossref","unstructured":"Zulman J Jaffe R Tala N. Evidence that the malignant lymphoma of Sj8gren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 1978;299: 1215\u201320.","DOI":"10.1056\/NEJM197811302992204"},{"key":"e_1_2_1_64_1","first-page":"199","article-title":"The spectrum of benign to malignant lymphoproliferation in Sj8gren's syndrome","volume":"10","author":"Anderson LG","year":"1972","unstructured":"Anderson LG, Talal N. The spectrum of benign to malignant lymphoproliferation in Sj8gren's syndrome. Clin Exp Immunol 1972;10:199\u2013221.","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_65_1","doi-asserted-by":"crossref","unstructured":"Walters MT Stevenson FK Heibert A et al. Lymphoma in Sj8gren's syndrome: urinary monoclonal free light chains as a diagnostic aid and a means of tumor monitoring. Scand J Rheumatol 1986;15 Supp1:114\u20137.","DOI":"10.1080\/15027732.1986.12461392"}],"container-title":["Scandinavian Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/030097401316909486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:23:20Z","timestamp":1772706200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/030097401316909486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1080\/030097401316909486"],"URL":"https:\/\/doi.org\/10.1080\/030097401316909486","relation":{},"ISSN":["0300-9742","1502-7732"],"issn-type":[{"value":"0300-9742","type":"print"},{"value":"1502-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}